Stay updated with breaking news from Cingulate Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
19.09.2022 - Data Demonstrated Ability of CTx-2103 to Deliver a Single Administration of Triple-Release Buspirone – Setting the Stage for Future Trials Employing Cingulate’s Precision Timed Release (PTR) Technology CTx-2103 has the Potential to be the First ... Seite 1
11.08.2022 - $5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision ...
KC Business Veteran, Two-Time Award Winner, Helped Lead Cingulate to 2021 IPO...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.